Feb 19, 2026 First Group Leaders announced for new dedicated Parkinson's Research Centre In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research... Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther conditionsParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Research Division Research Division Prof Gabriel Balmus Group Leader UK DRI at Cambridge Identifying genetic and environmental factors involved in DNA damage, neurodegeneration and ageing in neurons Learn more Prof Gabriel Balmus Dr Mathieu Bourdenx Group Leader Learn more Dr Mathieu Bourdenx Prof Vincent Dion Group Leader UK DRI at Cardiff Developing new treatments to stop the progression of expanded repeat disorders Learn more Prof Vincent Dion Prof Karen Duff Centre Director UK DRI at UCL Revealing the molecular causes and consequences of tauopathy in Alzheimer's disease and frontotemporal dementia Learn more Prof Karen Duff Dr Emil Gustavsson Group Leader Interpreting genetic risk through transcriptomics to advance neurodegenerative therapies Learn more Dr Emil Gustavsson Prof Sir John Hardy Group Leader UK DRI at UCL Harnessing genetics to build a better understanding of dementia Learn more Prof Sir John Hardy Prof Henry Houlden Group Leader Parkinson's Research Centre at UCL Investigating Parkinson’s and degenerative movement disorders across the full spectrum of patient populations Learn more Prof Henry Houlden Prof Adrian Isaacs Group Leader UK DRI at UCL Deciphering the fundamental molecular causes of frontotemporal dementia and ALS Learn more Prof Adrian Isaacs Dr Sarah Marzi Group Leader UK DRI at King's Investigating how epigenetics regulates biological mechanisms in health and disease Learn more Dr Sarah Marzi Prof Paul Matthews Group Leader UK DRI at Imperial Exploring neuronal vulnerability and genetic risk variants in Alzheimer’s progression Learn more Prof Paul Matthews Dr Sarah Mizielinska Group Leader UK DRI at King's Understanding the precise mechanisms of nucleocytoplasmic dysfunction in FTD and ALS Learn more Dr Sarah Mizielinska Dr Alexi Nott Group Leader UK DRI at Imperial Investigating how the epigenome regulates cell type specific gene expression in ageing-related brain disorders Learn more Dr Alexi Nott Pagination Current page 1 Page 2 Next page › Last page Last
Prof Gabriel Balmus Group Leader UK DRI at Cambridge Identifying genetic and environmental factors involved in DNA damage, neurodegeneration and ageing in neurons Learn more Prof Gabriel Balmus
Prof Vincent Dion Group Leader UK DRI at Cardiff Developing new treatments to stop the progression of expanded repeat disorders Learn more Prof Vincent Dion
Prof Karen Duff Centre Director UK DRI at UCL Revealing the molecular causes and consequences of tauopathy in Alzheimer's disease and frontotemporal dementia Learn more Prof Karen Duff
Dr Emil Gustavsson Group Leader Interpreting genetic risk through transcriptomics to advance neurodegenerative therapies Learn more Dr Emil Gustavsson
Prof Sir John Hardy Group Leader UK DRI at UCL Harnessing genetics to build a better understanding of dementia Learn more Prof Sir John Hardy
Prof Henry Houlden Group Leader Parkinson's Research Centre at UCL Investigating Parkinson’s and degenerative movement disorders across the full spectrum of patient populations Learn more Prof Henry Houlden
Prof Adrian Isaacs Group Leader UK DRI at UCL Deciphering the fundamental molecular causes of frontotemporal dementia and ALS Learn more Prof Adrian Isaacs
Dr Sarah Marzi Group Leader UK DRI at King's Investigating how epigenetics regulates biological mechanisms in health and disease Learn more Dr Sarah Marzi
Prof Paul Matthews Group Leader UK DRI at Imperial Exploring neuronal vulnerability and genetic risk variants in Alzheimer’s progression Learn more Prof Paul Matthews
Dr Sarah Mizielinska Group Leader UK DRI at King's Understanding the precise mechanisms of nucleocytoplasmic dysfunction in FTD and ALS Learn more Dr Sarah Mizielinska
Dr Alexi Nott Group Leader UK DRI at Imperial Investigating how the epigenome regulates cell type specific gene expression in ageing-related brain disorders Learn more Dr Alexi Nott
